Logo image
Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry
Journal article   Open access   Peer reviewed

Data-Driven Patient Clustering and Differential Clinical Outcomes in the Brigham and Women's Rheumatoid Arthritis Sequential Study Registry

Jeffrey R Curtis, Michael Weinblatt, Kenneth Saag, Vivian P Bykerk, Daniel E Furst, Stefano Fiore, Gregory St John, Toshio Kimura, Shen Zheng, Clifton O Bingham, 3rd, …
Arthritis care & research (2010), v 73(4), pp 471-480
Apr 2021
PMID: 33002337
url
https://doi.org/10.1002/acr.24471View
Published, Version of Record (VoR)CC BY-NC V4.0 Open

Abstract

Adolescent Adult Aged Aged, 80 and over Arthritis, Rheumatoid - diagnosis Arthritis, Rheumatoid - epidemiology Arthritis, Rheumatoid - therapy Boston Cluster Analysis Cross-Sectional Studies Data Mining Disease Progression Female Health Status Humans Incidence Male Middle Aged Multimorbidity Phenotype Principal Component Analysis Prospective Studies Registries Risk Assessment Risk Factors Social Determinants of Health Socioeconomic Factors Time Factors Treatment Outcome Young Adult
To use unbiased, data-driven, principal component (PC) and cluster analysis to identify patient phenotypes of rheumatoid arthritis (RA) that might exhibit distinct trajectories of disease progression, response to treatment, and risk for adverse events. Patient demographic, socioeconomic, health, and disease characteristics recorded at entry into a large, single-center, prospective observational registry cohort, the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS), were harmonized using PC analysis to reduce dimensionality and collinearity. The number of PCs was established by eigenvalue >1, cumulative variance, and interpretability. The resulting PCs were used to cluster patients using a K-means approach. Longitudinal clinical outcomes were compared between the clusters over 2 years. Analysis of 142 variables from 1,443 patients identified 41 PCs that accounted for 77% of the cumulative variance in the data set. Cluster analysis distinguished 5 patient clusters: 1) less RA disease activity/multimorbidity, shorter RA duration, lower incidence of comorbidities; 2) less RA disease activity/multimorbidity, longer RA duration, more infections, psychiatric comorbidities, health care utilization; 3) moderate RA disease activity/multimorbidity, more neurologic comorbidity; 4) more RA disease activity/multimorbidity, shorter RA duration, more metabolic comorbidity, higher body mass index; 5) more RA disease activity/multimorbidity, longer RA duration, more hepatic, orthopedic comorbidity and RA-related surgeries. The clusters exhibited differences in clinical outcomes over 2 years of follow-up. Data-driven analysis of the BRASS registry identified 5 distinct phenotypes of RA. These results illustrate the potential of data-driven patient profiling as a tool to support personalized medicine in RA. Validation in an independent data set is ongoing.

Metrics

12 Record Views
13 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Industry collaboration
Domestic collaboration
International collaboration
Web of Science research areas
Rheumatology
Logo image